⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 14, 2024

[Analysis of the efficacy and safety of bone disease treatment in patients with newly diagnosed multiple myeloma treated with denosumab or zoledronic acid].

Yuanzheng Ma X B Xiao Yanchen Liu X L Chen Shunzong Yuan Sihai Zhao Yanrong Lu Han Yin J L Chen Y Q Wang N N Cheng Po‐Hao Feng W R Huang

View at Publisher

Ask AI

Bookmark

Share

Abstract

This study investigated the efficacy and safety of denosumab (DENOS) versus zoledronic acid (ZOL) in the bone disease treatment of newly diagnosed multiple myeloma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ma et al. (2024) studied this question.

synapsesocial.com/papers/68e6f3b2b6db64358766e845 https://doi.org/10.3760/cma.j.cn121090-20231203-00289

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Denosumab versus zoledronic acid in patients with breast cancer: A propensity-matched real-world time-to-event analysis.Cohort Study · 2026
2Final analysis of the evaluation of safety and efficacy of denosumab in patients with multiple myeloma and severe renal impairment: An IMWG bone subcommittee study2025
3Switching from Zoledronic Acid to Denosumab for Bone Modification Therapy in Patients with Malignant Tumors and Renal Insufficiency: A Retrospective Case Series and Literature Review.2025 · 1 citations
4Comparison of the Efficacy of Zoledronate and Denosumab in Patients with Acute Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial2024 · 9 citations
5Efficacy and Safety of Denosumab and Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis—A Comparative Study of Bone Metabolism, Bone Density, and Sex Hormone Levels2025 · 2 citations

More related papers

Abstract PS1-08-17: Real-world outcomes comparing zoledronic acid and denosumab in patients with metastatic breast cancer and bone metastases: A propensity score matched analysis from a global federated health research network2026
Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis2024
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial2011